| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.17e-06 | 26 | 147 | 5 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 2.08e-06 | 29 | 147 | 5 | GO:0004629 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP42 RALGAPA1 ARHGAP32 RANBP3 DOCK10 ALS2 BCR PLEKHG1 ARHGEF33 PLCB1 HERC1 ARHGAP21 VAV2 PLCE1 | 2.36e-05 | 507 | 147 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP42 RALGAPA1 ARHGAP32 RANBP3 DOCK10 ALS2 BCR PLEKHG1 ARHGEF33 PLCB1 HERC1 ARHGAP21 VAV2 PLCE1 | 2.36e-05 | 507 | 147 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 8.19e-05 | 97 | 147 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.19e-04 | 231 | 147 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | satellite DNA binding | 3.20e-04 | 4 | 147 | 2 | GO:0003696 | |
| GeneOntologyMolecularFunction | lipase activity | 5.56e-04 | 138 | 147 | 6 | GO:0016298 | |
| GeneOntologyMolecularFunction | microfibril binding | 7.92e-04 | 6 | 147 | 2 | GO:0050436 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ARHGAP42 RALGAPA1 DOK1 ARHGAP32 ABCA1 DOCK10 ALS2 GRIN2B BCR PLEKHG1 MET FBP1 G3BP1 HACE1 ARHGAP21 VAV2 PLCE1 | 2.05e-07 | 538 | 143 | 17 | GO:0007264 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 5.71e-07 | 24 | 143 | 5 | GO:0048015 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | ARHGAP42 RALGAPA1 ARHGAP32 ABCA1 ALS2 GRIN2B BCR PLEKHG1 MET FBP1 ARHGAP21 VAV2 | 3.69e-06 | 333 | 143 | 12 | GO:0051056 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | DOK1 ANKS1B DCN BCR GFRA1 EPN2 ADAMTS12 MET FRK ZNF106 CSHL1 ADGRE3 PLCB1 KIT VAV2 PLCE1 | 6.31e-05 | 747 | 143 | 16 | GO:0007169 |
| Domain | PLC-beta | 3.79e-09 | 4 | 148 | 4 | IPR016280 | |
| Domain | EF-hand_like | 8.22e-08 | 15 | 148 | 5 | PF09279 | |
| Domain | PI-PLC-Y | 8.22e-08 | 15 | 148 | 5 | PF00387 | |
| Domain | PLCYc | 8.22e-08 | 15 | 148 | 5 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 8.22e-08 | 15 | 148 | 5 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 8.22e-08 | 15 | 148 | 5 | PS50008 | |
| Domain | PI-PLC_fam | 8.22e-08 | 15 | 148 | 5 | IPR001192 | |
| Domain | PLC_EF-hand-like | 8.22e-08 | 15 | 148 | 5 | IPR015359 | |
| Domain | PI-PLC-X | 2.30e-07 | 18 | 148 | 5 | PF00388 | |
| Domain | PLCXc | 2.30e-07 | 18 | 148 | 5 | SM00148 | |
| Domain | PH_dom-like | ARHGAP42 DOK1 RANBP3 ANKS1B DOCK10 ALS2 BCR PLEKHG1 OSBP PLCB1 PLCB2 PLCB3 PLCB4 ARHGAP21 VAV2 PLCE1 | 2.83e-07 | 426 | 148 | 16 | IPR011993 |
| Domain | PIPLC_X_DOMAIN | 3.10e-07 | 19 | 148 | 5 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 3.10e-07 | 19 | 148 | 5 | IPR000909 | |
| Domain | PLC-beta_CS | 4.88e-07 | 3 | 148 | 3 | IPR009535 | |
| Domain | PLC-beta_C | 4.88e-07 | 3 | 148 | 3 | PF08703 | |
| Domain | PLC-beta_C | 4.88e-07 | 3 | 148 | 3 | IPR014815 | |
| Domain | DUF1154 | 4.88e-07 | 3 | 148 | 3 | PF06631 | |
| Domain | - | 1.37e-06 | 25 | 148 | 5 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.37e-06 | 25 | 148 | 5 | IPR017946 | |
| Domain | - | ARHGAP42 DOK1 RANBP3 ANKS1B DOCK10 ALS2 BCR PLEKHG1 OSBP PLCB3 PLCB4 ARHGAP21 VAV2 PLCE1 | 2.85e-06 | 391 | 148 | 14 | 2.30.29.30 |
| Domain | ULD | 6.24e-05 | 2 | 148 | 2 | IPR032392 | |
| Domain | CUTL | 6.24e-05 | 2 | 148 | 2 | IPR032355 | |
| Domain | ULD | 6.24e-05 | 2 | 148 | 2 | PF16534 | |
| Domain | CUTL | 6.24e-05 | 2 | 148 | 2 | PF16557 | |
| Domain | C2 | 8.37e-05 | 131 | 148 | 7 | PF00168 | |
| Domain | C2 | 1.11e-04 | 137 | 148 | 7 | SM00239 | |
| Domain | C2 | 1.39e-04 | 142 | 148 | 7 | PS50004 | |
| Domain | - | 1.79e-04 | 148 | 148 | 7 | 2.60.40.150 | |
| Domain | RhoGEF | 2.34e-04 | 70 | 148 | 5 | PF00621 | |
| Domain | DH_2 | 2.34e-04 | 70 | 148 | 5 | PS50010 | |
| Domain | - | 2.50e-04 | 71 | 148 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 2.50e-04 | 71 | 148 | 5 | IPR000219 | |
| Domain | GDS_CDC24_CS | 2.51e-04 | 39 | 148 | 4 | IPR001331 | |
| Domain | C2_dom | 3.36e-04 | 164 | 148 | 7 | IPR000008 | |
| Domain | Bile_Hydr_Trans | 3.70e-04 | 4 | 148 | 2 | PF04775 | |
| Domain | Serpin_B9/Maspin | 3.70e-04 | 4 | 148 | 2 | IPR000240 | |
| Domain | Thio_Ohase/aa_AcTrfase | 3.70e-04 | 4 | 148 | 2 | IPR006862 | |
| Domain | Acyl-CoA_thioEstase_long-chain | 3.70e-04 | 4 | 148 | 2 | IPR016662 | |
| Domain | PH | 3.81e-04 | 278 | 148 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 3.91e-04 | 279 | 148 | 9 | PS50003 | |
| Domain | PH_domain | 4.01e-04 | 280 | 148 | 9 | IPR001849 | |
| Domain | PH | 4.89e-04 | 229 | 148 | 8 | PF00169 | |
| Domain | BAAT_C | 6.14e-04 | 5 | 148 | 2 | IPR014940 | |
| Domain | Autophagy-rel_C | 6.14e-04 | 5 | 148 | 2 | IPR015412 | |
| Domain | ATG_C | 6.14e-04 | 5 | 148 | 2 | PF09333 | |
| Domain | BAAT_C | 6.14e-04 | 5 | 148 | 2 | PF08840 | |
| Domain | ADAM_spacer1 | 7.69e-04 | 23 | 148 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 7.69e-04 | 23 | 148 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 8.73e-04 | 24 | 148 | 3 | IPR013273 | |
| Domain | - | 1.14e-03 | 261 | 148 | 8 | 1.10.238.10 | |
| Domain | CUT | 1.28e-03 | 7 | 148 | 2 | PS51042 | |
| Domain | CUT | 1.28e-03 | 7 | 148 | 2 | PF02376 | |
| Domain | CUT_dom | 1.28e-03 | 7 | 148 | 2 | IPR003350 | |
| Domain | CUT | 1.28e-03 | 7 | 148 | 2 | SM01109 | |
| Domain | RhoGAP | 1.48e-03 | 62 | 148 | 4 | SM00324 | |
| Domain | RhoGAP | 1.57e-03 | 63 | 148 | 4 | PF00620 | |
| Domain | DH_1 | 1.57e-03 | 63 | 148 | 4 | PS00741 | |
| Domain | RhoGAP_dom | 1.66e-03 | 64 | 148 | 4 | IPR000198 | |
| Domain | RHOGAP | 1.66e-03 | 64 | 148 | 4 | PS50238 | |
| Domain | - | 1.66e-03 | 64 | 148 | 4 | 1.10.555.10 | |
| Domain | Chorein_N | 1.69e-03 | 8 | 148 | 2 | PF12624 | |
| Domain | - | 1.69e-03 | 8 | 148 | 2 | 3.30.890.10 | |
| Domain | VPS13_N | 1.69e-03 | 8 | 148 | 2 | IPR026854 | |
| Domain | - | 1.91e-03 | 283 | 148 | 8 | 1.10.10.60 | |
| Domain | RhoGEF | 2.08e-03 | 68 | 148 | 4 | SM00325 | |
| Domain | EF-hand-dom_pair | 2.08e-03 | 287 | 148 | 8 | IPR011992 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.44e-09 | 10 | 116 | 5 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.54e-08 | 11 | 116 | 5 | M49033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.22e-08 | 13 | 116 | 5 | M47656 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 6.45e-08 | 6 | 116 | 4 | M47548 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY | 1.49e-07 | 7 | 116 | 4 | M47505 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 4.86e-07 | 20 | 116 | 5 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.34e-07 | 21 | 116 | 5 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.15e-07 | 22 | 116 | 5 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.15e-07 | 22 | 116 | 5 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY | 8.80e-07 | 10 | 116 | 4 | M47644 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.03e-06 | 23 | 116 | 5 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY | 1.37e-06 | 11 | 116 | 4 | M47637 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.40e-06 | 98 | 116 | 8 | M39830 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.98e-06 | 26 | 116 | 5 | M27053 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.05e-06 | 12 | 116 | 4 | M47649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY | 2.05e-06 | 12 | 116 | 4 | M47628 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.92e-06 | 28 | 116 | 5 | MM14711 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 4.18e-06 | 30 | 116 | 5 | M42578 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.10e-06 | 54 | 116 | 6 | M26911 | |
| Pathway | WP_GPR40_PATHWAY | 5.54e-06 | 15 | 116 | 4 | M39526 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 6.83e-06 | 33 | 116 | 5 | M39745 | |
| Pathway | KEGG_GAP_JUNCTION | 9.06e-06 | 90 | 116 | 7 | M4013 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.21e-05 | 94 | 116 | 7 | MM15598 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.22e-05 | 18 | 116 | 4 | M47659 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 1.53e-05 | 19 | 116 | 4 | M47596 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.53e-05 | 19 | 116 | 4 | M47543 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.59e-05 | 39 | 116 | 5 | MM14496 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.33e-05 | 70 | 116 | 6 | M3115 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY | 2.34e-05 | 21 | 116 | 4 | M47638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.34e-05 | 21 | 116 | 4 | M47542 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.84e-05 | 22 | 116 | 4 | M39795 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 2.95e-05 | 8 | 116 | 3 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.95e-05 | 8 | 116 | 3 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.95e-05 | 8 | 116 | 3 | MM15100 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.20e-05 | 74 | 116 | 6 | MM15962 | |
| Pathway | WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3 | 3.46e-05 | 75 | 116 | 6 | M39568 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 3.62e-05 | 46 | 116 | 5 | M48317 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 3.73e-05 | 76 | 116 | 6 | M9052 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.47e-05 | 48 | 116 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.47e-05 | 48 | 116 | 5 | MM14589 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.48e-05 | 115 | 116 | 7 | M9387 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 4.94e-05 | 49 | 116 | 5 | M40046 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 5.45e-05 | 50 | 116 | 5 | M47951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 5.66e-05 | 26 | 116 | 4 | M47557 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 6.25e-05 | 10 | 116 | 3 | M1825 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 7.65e-05 | 28 | 116 | 4 | M47508 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 7.93e-05 | 54 | 116 | 5 | M3896 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 8.00e-05 | 87 | 116 | 6 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 8.53e-05 | 88 | 116 | 6 | M41810 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 8.54e-05 | 11 | 116 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 8.54e-05 | 11 | 116 | 3 | MM15035 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 9.67e-05 | 90 | 116 | 6 | M6467 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 9.77e-05 | 175 | 116 | 8 | MM15599 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.10e-04 | 178 | 116 | 8 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.15e-04 | 31 | 116 | 4 | M47554 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 1.16e-04 | 93 | 116 | 6 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 1.23e-04 | 94 | 116 | 6 | M41818 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.38e-04 | 184 | 116 | 8 | M41809 | |
| Pathway | KEGG_MELANOGENESIS | 1.83e-04 | 101 | 116 | 6 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.83e-04 | 101 | 116 | 6 | M1979 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 2.73e-04 | 70 | 116 | 5 | M8232 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 2.87e-04 | 39 | 116 | 4 | M39905 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.91e-04 | 155 | 116 | 7 | M41808 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.92e-04 | 71 | 116 | 5 | MM14491 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.03e-04 | 261 | 116 | 9 | M42565 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 6.48e-04 | 21 | 116 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 6.48e-04 | 21 | 116 | 3 | MM15159 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 1.09e-03 | 25 | 116 | 3 | M39384 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 1.37e-03 | 7 | 116 | 2 | M27457 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 1.37e-03 | 7 | 116 | 2 | MM15199 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.48e-03 | 326 | 116 | 9 | M39379 | |
| Pathway | PID_IL8_CXCR1_PATHWAY | 1.53e-03 | 28 | 116 | 3 | M252 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.58e-03 | 61 | 116 | 4 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.68e-03 | 62 | 116 | 4 | M27321 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.78e-03 | 63 | 116 | 4 | M8 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.79e-03 | 271 | 116 | 8 | MM15406 | |
| Pathway | REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD | 1.82e-03 | 8 | 116 | 2 | M27259 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.87e-03 | 30 | 116 | 3 | M18193 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.97e-03 | 108 | 116 | 5 | M17034 | |
| Pathway | PID_AR_NONGENOMIC_PATHWAY | 2.06e-03 | 31 | 116 | 3 | M213 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 2.26e-03 | 32 | 116 | 3 | MM15143 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 2.26e-03 | 32 | 116 | 3 | M14309 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.33e-03 | 9 | 116 | 2 | M47490 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 2.40e-03 | 113 | 116 | 5 | M39669 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 2.41e-03 | 165 | 116 | 6 | M39400 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 2.47e-03 | 33 | 116 | 3 | MM15027 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 2.49e-03 | 166 | 116 | 6 | M16024 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.49e-03 | 69 | 116 | 4 | MM15596 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 2.61e-03 | 288 | 116 | 8 | M16864 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.63e-03 | 70 | 116 | 4 | M41806 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 2.63e-03 | 70 | 116 | 4 | MM15597 | |
| Pathway | PID_IL8_CXCR2_PATHWAY | 2.70e-03 | 34 | 116 | 3 | M210 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 2.77e-03 | 71 | 116 | 4 | MM15947 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.91e-03 | 72 | 116 | 4 | MM14631 | |
| Pubmed | 1.79e-10 | 9 | 151 | 5 | 7589147 | ||
| Pubmed | 1.79e-10 | 9 | 151 | 5 | 10501179 | ||
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 9753089 | ||
| Pubmed | Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. | 3.41e-10 | 4 | 151 | 4 | 9305844 | |
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 15174099 | ||
| Pubmed | Phospholipase C-β1 potentiates glucose-stimulated insulin secretion. | 3.41e-10 | 4 | 151 | 4 | 31268747 | |
| Pubmed | 3.41e-10 | 4 | 151 | 4 | 23006664 | ||
| Pubmed | 7.65e-10 | 24 | 151 | 6 | 10843712 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 4.19e-09 | 15 | 151 | 5 | 28578927 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | RALGAPA1 ARHGAP32 TMEM51 ABCC5 ADCY9 CEMIP2 EPN2 PLIN2 MET CELSR2 MTOR PLCB1 PLCB3 PCDH18 ARHGAP21 VPS13B | 4.29e-09 | 569 | 151 | 16 | 30639242 |
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 8739298 | ||
| Pubmed | 5.09e-09 | 6 | 151 | 4 | 2841328 | ||
| Pubmed | 1.18e-08 | 18 | 151 | 5 | 1979339 | ||
| Pubmed | Genetic dissection of gustatory sensitivity to bitterness (sucrose octaacetate) in mice. | 1.18e-08 | 7 | 151 | 4 | 10609087 | |
| Pubmed | 4.56e-08 | 23 | 151 | 5 | 9730685 | ||
| Pubmed | 4.56e-08 | 23 | 151 | 5 | 9278385 | ||
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 7.03e-08 | 10 | 151 | 4 | 2033248 | |
| Pubmed | 7.03e-08 | 10 | 151 | 4 | 23295235 | ||
| Pubmed | 1.08e-07 | 27 | 151 | 5 | 20336759 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 ARHGAP32 LIMA1 TTC28 RANBP3 ALS2 BCR EPN2 PLEKHG1 ZNF106 C2CD3 MTOR CSNK1D CSNK1E OTUD7A RAI14 ARHGAP21 | 2.32e-07 | 861 | 151 | 17 | 36931259 |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 9188725 | ||
| Pubmed | 4.86e-07 | 67 | 151 | 6 | 29254152 | ||
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 6.45e-07 | 38 | 151 | 5 | 12482669 | |
| Pubmed | 6.74e-07 | 225 | 151 | 9 | 12168954 | ||
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 15611108 | ||
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 11941371 | ||
| Pubmed | 9.33e-07 | 234 | 151 | 9 | 36243803 | ||
| Pubmed | RALGAPA1 ARHGAP32 LIMA1 HSP90B2P PPP1R12B MYO18A ANKS1B GRIN2B SUCLG1 BCR EPN2 ITPR2 PHKB NWD2 G3BP1 KCND3 CSNK1D TRAPPC10 RAI14 CDC5L ARHGAP21 | 1.09e-06 | 1431 | 151 | 21 | 37142655 | |
| Pubmed | 1.93e-06 | 21 | 151 | 4 | 30270038 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 30720883 | ||
| Pubmed | RALGAPA1 ARHGAP32 MYO18A ANKS1B ITPR2 NWD2 CSNK1D CSNK1E TRAPPC10 RAI14 ARHGAP21 | 3.10e-06 | 430 | 151 | 11 | 32581705 | |
| Pubmed | KLHL28 PPP1R12B POLR2A PELI3 ADAMTS12 FRK KCND3 CSNK1D CSNK1E ADAMTS15 PLCB1 PPIL2 PLCB2 PLCB3 | 3.99e-06 | 730 | 151 | 14 | 34857952 | |
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 15623527 | ||
| Pubmed | 6.61e-06 | 9 | 151 | 3 | 20400778 | ||
| Pubmed | Phospholipase C-beta 1 is a GTPase-activating protein for Gq/11, its physiologic regulator. | 6.61e-06 | 9 | 151 | 3 | 1322796 | |
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 1.27e-05 | 33 | 151 | 4 | 8672127 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.64e-05 | 420 | 151 | 10 | 28065597 | |
| Pubmed | ARHGAP32 TMEM51 ADCY9 CEMIP2 EPN2 MET CELSR2 PLCB1 RAI14 ARHGAP21 | 1.67e-05 | 421 | 151 | 10 | 36976175 | |
| Pubmed | Ins(1,4,5)P(3) regulates phospholipase Cbeta1 expression in cardiomyocytes. | 1.87e-05 | 2 | 151 | 2 | 18692062 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9632646 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 17114052 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25543122 | ||
| Pubmed | MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor. | 1.87e-05 | 2 | 151 | 2 | 36139568 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15075187 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16314422 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25404202 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16566000 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 34543471 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25323550 | ||
| Pubmed | Maternal Hypertension-Related Genotypes and Congenital Heart Defects. | 1.87e-05 | 2 | 151 | 2 | 32710738 | |
| Pubmed | Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation. | 1.87e-05 | 2 | 151 | 2 | 19109250 | |
| Pubmed | Critical role for mast cell Stat5 activity in skin inflammation. | 1.87e-05 | 2 | 151 | 2 | 24412367 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 26434682 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 24424021 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 35314946 | ||
| Pubmed | Leucine promotes leptin receptor expression in mouse C2C12 myotubes through the mTOR pathway. | 1.87e-05 | 2 | 151 | 2 | 20151325 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 20841608 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22745058 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 25375091 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30621510 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 19043076 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30520540 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 34358226 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22768106 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 24475116 | ||
| Pubmed | Glucose regulates heat shock factor 1 transcription activity via mTOR pathway in HCC cell lines. | 1.87e-05 | 2 | 151 | 2 | 26010766 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 37931691 | ||
| Pubmed | Satb1 and Satb2 are dispensable for X chromosome inactivation in mice. | 1.87e-05 | 2 | 151 | 2 | 23079603 | |
| Pubmed | Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. | 1.87e-05 | 2 | 151 | 2 | 8757502 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 22981886 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30554401 | ||
| Pubmed | Functional rescue of Kv4.3 channel tetramerization mutants by KChIP4a. | 1.87e-05 | 2 | 151 | 2 | 20550899 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15664177 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 2.08e-05 | 432 | 151 | 10 | 23455922 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | COL7A1 ARHGAP32 POLR2A ABCC5 HEATR1 KIF24 ADAMTS12 CSHL1 PRCP A2ML1 UNC80 | 3.17e-05 | 552 | 151 | 11 | 10737800 |
| Pubmed | 3.51e-05 | 15 | 151 | 3 | 11118617 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LIMA1 POLR2A MYO18A RFC1 ZNF106 OSBP G3BP1 CSNK1E TRAPPC10 AFF1 PLCB3 HSF1 RAVER1 | 3.57e-05 | 774 | 151 | 13 | 15302935 |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 4.04e-05 | 211 | 151 | 7 | 24097068 | |
| Pubmed | 4.31e-05 | 16 | 151 | 3 | 31823782 | ||
| Pubmed | 4.82e-05 | 217 | 151 | 7 | 34048709 | ||
| Pubmed | 5.22e-05 | 17 | 151 | 3 | 21431469 | ||
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 5.27e-05 | 47 | 151 | 4 | 19167335 | |
| Pubmed | RALGAPA1 ARHGAP32 PPP1R12B TMEM51 POLR2A DHX38 ADCY9 CEMIP2 ITPR2 PHKB C2CD3 RAI14 CDC5L HERC1 RAVER1 | 5.58e-05 | 1049 | 151 | 15 | 27880917 | |
| Pubmed | miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. | 5.60e-05 | 3 | 151 | 2 | 24810336 | |
| Pubmed | A unique fold of phospholipase C-beta mediates dimerization and interaction with G alpha q. | 5.60e-05 | 3 | 151 | 2 | 11753430 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 25868389 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 18079968 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 30551391 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 25724478 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 25665722 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 32321936 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 31353086 | ||
| Pubmed | Regulation of phospholipase C-beta 3 activity by Na+/H+ exchanger regulatory factor 2. | 5.60e-05 | 3 | 151 | 2 | 10748023 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 8786104 | ||
| Pubmed | The AKT-independent MET-V-ATPase-MTOR axis suppresses liver cancer vaccination. | 5.60e-05 | 3 | 151 | 2 | 32764535 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 23903187 | ||
| Pubmed | Identification of PTE2, a human peroxisomal long-chain acyl-CoA thioesterase. | 5.60e-05 | 3 | 151 | 2 | 10944470 | |
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 17675482 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 19805222 | ||
| Pubmed | 5.60e-05 | 3 | 151 | 2 | 8687404 | ||
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 9.89e-08 | 19 | 114 | 5 | 832 | |
| GeneFamily | Phospholipases | 6.44e-06 | 42 | 114 | 5 | 467 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.00e-05 | 66 | 114 | 5 | 722 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.38e-03 | 9 | 114 | 2 | 527 | |
| GeneFamily | Acyl-CoA thioesterases | 1.72e-03 | 10 | 114 | 2 | 41 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.96e-03 | 206 | 114 | 6 | 682 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 2.09e-03 | 11 | 114 | 2 | 1025 | |
| GeneFamily | Collagens | 3.04e-03 | 46 | 114 | 3 | 490 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.86e-03 | 50 | 114 | 3 | 721 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGAP32 TTC28 BAZ2B PPP1R12B ITPR2 KMT2C AFF1 PLCB4 HERC1 VPS13B | 1.67e-09 | 199 | 151 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.90e-08 | 200 | 151 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 181 | 151 | 8 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-07 | 183 | 151 | 8 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.89e-07 | 190 | 151 | 8 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 4.27e-07 | 200 | 151 | 8 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 168 | 151 | 7 | e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 168 | 151 | 7 | b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-06 | 178 | 151 | 7 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-06 | 178 | 151 | 7 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-06 | 180 | 151 | 7 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.88e-06 | 181 | 151 | 7 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-06 | 183 | 151 | 7 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-06 | 185 | 151 | 7 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 187 | 151 | 7 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 3.57e-06 | 187 | 151 | 7 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-06 | 187 | 151 | 7 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 3.79e-06 | 122 | 151 | 6 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.83e-06 | 189 | 151 | 7 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-06 | 189 | 151 | 7 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-06 | 189 | 151 | 7 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 190 | 151 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 190 | 151 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.10e-06 | 191 | 151 | 7 | 2b10a73c5d80e83d67a7121fb004a1aa86a537ef | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.10e-06 | 191 | 151 | 7 | 02e1ae144da7274171e055356d10e8d175c5347f | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM3|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.10e-06 | 191 | 151 | 7 | 05867b96199a46a415848409130697c810d18937 | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.10e-06 | 191 | 151 | 7 | 4c4f50a502e3f6768a89df686fa2830b83b8b33f | |
| ToppCell | BAL-Severe-Myeloid-TRAM|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.10e-06 | 191 | 151 | 7 | de7c88bb46f794291025ef121a89fcd94dea4ffe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 192 | 151 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.24e-06 | 192 | 151 | 7 | 34505a13b8a47c9286c560122fa7861b9c331a08 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.24e-06 | 192 | 151 | 7 | 57c1410ebf90c230993e065eb78385daa3360960 | |
| ToppCell | COVID-19-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 4.39e-06 | 193 | 151 | 7 | 6e6a7f4e50c8ae70bc187b9ce77140a7049dd288 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.39e-06 | 193 | 151 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.54e-06 | 194 | 151 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 4.86e-06 | 196 | 151 | 7 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 4.86e-06 | 196 | 151 | 7 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.02e-06 | 197 | 151 | 7 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-06 | 197 | 151 | 7 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-06 | 197 | 151 | 7 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.02e-06 | 197 | 151 | 7 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.02e-06 | 197 | 151 | 7 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.37e-06 | 199 | 151 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.37e-06 | 199 | 151 | 7 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.55e-06 | 200 | 151 | 7 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 200 | 151 | 7 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.55e-06 | 200 | 151 | 7 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.55e-06 | 200 | 151 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.55e-06 | 200 | 151 | 7 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.13e-05 | 165 | 151 | 6 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 168 | 151 | 6 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 168 | 151 | 6 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 168 | 151 | 6 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-05 | 168 | 151 | 6 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.44e-05 | 169 | 151 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.61e-05 | 171 | 151 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Tmem2_(Tmem2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.68e-05 | 103 | 151 | 5 | 287e945ef2f9646f1ff4a4c50fe6e8a5e7fe0d92 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 174 | 151 | 6 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.97e-05 | 175 | 151 | 6 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 175 | 151 | 6 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 175 | 151 | 6 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.97e-05 | 175 | 151 | 6 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 175 | 151 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-05 | 176 | 151 | 6 | cd4b9211652596c42e7af318bcd464681daebb10 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.16e-05 | 177 | 151 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-05 | 178 | 151 | 6 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-05 | 178 | 151 | 6 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.37e-05 | 179 | 151 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.37e-05 | 179 | 151 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.48e-05 | 180 | 151 | 6 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 3.58e-05 | 181 | 151 | 6 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-05 | 181 | 151 | 6 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.81e-05 | 183 | 151 | 6 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 183 | 151 | 6 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-05 | 183 | 151 | 6 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.81e-05 | 183 | 151 | 6 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.81e-05 | 183 | 151 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.81e-05 | 183 | 151 | 6 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.93e-05 | 184 | 151 | 6 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 184 | 151 | 6 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 184 | 151 | 6 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 184 | 151 | 6 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.93e-05 | 184 | 151 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-05 | 185 | 151 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.05e-05 | 185 | 151 | 6 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 187 | 151 | 6 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 188 | 151 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 188 | 151 | 6 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.43e-05 | 188 | 151 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.43e-05 | 188 | 151 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 188 | 151 | 6 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-05 | 188 | 151 | 6 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 188 | 151 | 6 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 189 | 151 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 189 | 151 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| Drug | C10A | 2.76e-08 | 6 | 151 | 4 | CID000041624 | |
| Drug | SKF83742 | 2.76e-08 | 6 | 151 | 4 | CID000130828 | |
| Drug | xanthate | 3.86e-08 | 50 | 151 | 7 | CID000008823 | |
| Drug | 8-iso Misoprostol | 1.78e-07 | 62 | 151 | 7 | CID004183806 | |
| Drug | decanoate | 2.32e-07 | 131 | 151 | 9 | CID000002969 | |
| Drug | 3-nitrocoumarin | 3.78e-07 | 10 | 151 | 4 | CID002799766 | |
| Drug | 2-chloroadenosine | 4.02e-07 | 102 | 151 | 8 | CID000008974 | |
| Drug | sulprostone | 4.58e-07 | 71 | 151 | 7 | CID005312153 | |
| Drug | isopetasin | 5.92e-07 | 11 | 151 | 4 | CID005318627 | |
| Drug | Lypressin | 6.61e-07 | 47 | 151 | 6 | CID000005772 | |
| Drug | chlorphentermine | 7.06e-07 | 26 | 151 | 5 | CID000010007 | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | ARHGAP32 RANBP3 CENPO LAMA3 BCR ADCY9 CSNK1E PPIL2 PLCB3 PRR14L | 8.15e-07 | 197 | 151 | 10 | 4774_DN |
| Drug | AC1L1II7 | 8.83e-07 | 12 | 151 | 4 | CID000004589 | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | COL7A1 ARHGAP32 MTF2 CENPO NPEPL1 EPN2 CSNK1E TRAPPC10 PLCB3 PLCE1 | 8.93e-07 | 199 | 151 | 10 | 7365_DN |
| Drug | alpha-methylhomocysteine-thiolactone | 1.71e-06 | 55 | 151 | 6 | CID000133014 | |
| Drug | AC1MQNLW | 1.77e-06 | 14 | 151 | 4 | CID003504628 | |
| Drug | ketanserin | 2.70e-06 | 131 | 151 | 8 | CID000003822 | |
| Drug | GF109203X | DOK1 GRIN2B ADCY9 SLC5A4 MTOR PLCB1 PLCB2 OXSM PLCB3 PLCB4 HSF1 PLCE1 | 3.06e-06 | 341 | 151 | 12 | CID000002396 |
| Drug | (?-Fluprostenol | 3.17e-06 | 61 | 151 | 6 | CID000003391 | |
| Drug | m-3M3FBS | 3.18e-06 | 16 | 151 | 4 | CID000761523 | |
| Drug | ST271 | 3.32e-06 | 35 | 151 | 5 | CID006439072 | |
| Drug | ADP beta S | 3.57e-06 | 96 | 151 | 7 | CID005310996 | |
| Drug | D 609 | 4.21e-06 | 64 | 151 | 6 | CID000002940 | |
| Drug | norathyriol | 4.41e-06 | 37 | 151 | 5 | CID005281656 | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.75e-06 | 188 | 151 | 9 | 5691_DN | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 6.39e-06 | 195 | 151 | 9 | 1649_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 6.66e-06 | 196 | 151 | 9 | 6344_DN | |
| Drug | sapintoxin A | 6.67e-06 | 19 | 151 | 4 | CID000108085 | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 6.93e-06 | 197 | 151 | 9 | 2698_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 6818_DN | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; PC3; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 6640_UP | |
| Drug | Pl-cs | 7.35e-06 | 107 | 151 | 7 | CID006450086 | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 7.52e-06 | 199 | 151 | 9 | 7421_DN | |
| Drug | spermidine | COL7A1 POLR2A GRIN2B CSNK1D CSNK1E PLCB1 PLCB2 PLCB3 PLCB4 PLCE1 | 7.64e-06 | 253 | 151 | 10 | CID000001102 |
| Drug | isopropyl-beta-D-thioglucoside | 8.83e-06 | 110 | 151 | 7 | CID000552632 | |
| Drug | IC 261 | 9.82e-06 | 7 | 151 | 3 | ctd:C411652 | |
| Drug | norfloxacin | 1.18e-05 | 45 | 151 | 5 | CID000004539 | |
| Drug | ryu | 1.34e-05 | 78 | 151 | 6 | CID005289321 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.34e-05 | 86 | 151 | 6 | CID000000805 | |
| Drug | NSC99363 | 3.03e-05 | 90 | 151 | 6 | CID000414014 | |
| Drug | aluminum | 3.24e-05 | 184 | 151 | 8 | CID000104727 | |
| Drug | AC1L1G9E | 3.36e-05 | 28 | 151 | 4 | CID000003586 | |
| Drug | eye gene | PPP1R12B MYO18A DCN ADCY9 KCND3 MTOR PLCB1 PLCB2 PLCB3 PLCB4 PLCE1 | 3.71e-05 | 369 | 151 | 11 | CID000004782 |
| Drug | Araf-TC | 3.88e-05 | 94 | 151 | 6 | CID000100788 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 3.93e-05 | 189 | 151 | 8 | CID000001413 | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; PC3; HT_HG-U133A | 4.39e-05 | 192 | 151 | 8 | 7378_DN | |
| Drug | AC1Q6T8I | 4.45e-05 | 30 | 151 | 4 | CID000000343 | |
| Drug | oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA | 4.72e-05 | 194 | 151 | 8 | 971_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 6347_DN | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; PC3; HT_HG-U133A | 4.72e-05 | 194 | 151 | 8 | 4474_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 3512_DN | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 4.90e-05 | 195 | 151 | 8 | 3470_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 2158_DN | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 5827_DN | |
| Drug | VX-680 | 5.09e-05 | 31 | 151 | 4 | CID005494449 | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 3048_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 2689_DN | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 6605_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 7230_DN | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 3865_DN | |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 5389_DN | |
| Drug | gentamicin | 5.46e-05 | 198 | 151 | 8 | CID000003467 | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 5.46e-05 | 198 | 151 | 8 | 961_DN | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; HL60; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 3092_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; HL60; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 2714_UP | |
| Drug | (+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 5.65e-05 | 199 | 151 | 8 | 954_DN | |
| Drug | Dibucaine [85-79-0]; Up 200; 11.6uM; PC3; HG-U133A | 5.65e-05 | 199 | 151 | 8 | 1889_UP | |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 3128_DN | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; HL60; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 2923_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.86e-05 | 200 | 151 | 8 | 5480_DN | |
| Drug | lead compounds | 6.54e-05 | 150 | 151 | 7 | CID000073212 | |
| Drug | milrinone | 6.54e-05 | 150 | 151 | 7 | CID000004197 | |
| Drug | spermine | COL7A1 PPP1R12B POLR2A GRIN2B CSNK1D CSNK1E PLCB1 PLCB2 PLCB3 PLCB4 PLCE1 | 6.69e-05 | 394 | 151 | 11 | CID000001103 |
| Drug | PtdIns(4)P | 6.85e-05 | 104 | 151 | 6 | CID000643965 | |
| Drug | aluminum fluoride | 7.81e-05 | 268 | 151 | 9 | CID000002124 | |
| Drug | monomethyl phthalate | 8.04e-05 | 155 | 151 | 7 | CID000020392 | |
| Drug | Lopac-P-178 | 8.33e-05 | 67 | 151 | 5 | CID005478935 | |
| Drug | spiperone | 8.45e-05 | 108 | 151 | 6 | CID000005265 | |
| Drug | sodium fluoride | 8.45e-05 | 108 | 151 | 6 | CID000005235 | |
| Drug | cetyltrimethylammonium bromide | 8.94e-05 | 68 | 151 | 5 | CID000002681 | |
| Drug | Substance P | 1.01e-04 | 343 | 151 | 10 | CID000036511 | |
| Drug | 2-(aminomethyl)pyrrolidine | 1.02e-04 | 161 | 151 | 7 | CID000072032 | |
| Drug | fenoldopam | 1.03e-04 | 70 | 151 | 5 | CID000003340 | |
| Drug | RHC 80267 | 1.03e-04 | 112 | 151 | 6 | CID000005063 | |
| Drug | guanine | COL7A1 SYNM ALS2 GRIN2B BCR ADCY9 PLIN2 ADK MTOR PLCB1 PLCB2 PLCB3 PLCB4 HERC1 MBD4 VAV2 PLCE1 | 1.05e-04 | 902 | 151 | 17 | CID000000764 |
| Drug | AC1Q6SH8 | 1.25e-04 | 116 | 151 | 6 | CID000000009 | |
| Drug | 2-phenylpyrimidine | 1.31e-04 | 3 | 151 | 2 | CID000593578 | |
| Drug | phosphatidate | 1.51e-04 | 432 | 151 | 11 | CID005460104 | |
| Drug | glycerol-3-phosphocholine | 1.54e-04 | 172 | 151 | 7 | CID000000823 | |
| Drug | papaverine | 1.77e-04 | 176 | 151 | 7 | CID000004680 | |
| Drug | AC1L1GFH | 1.88e-04 | 43 | 151 | 4 | CID000003660 | |
| Drug | L-quisqualic acid | 2.04e-04 | 180 | 151 | 7 | CID000001209 | |
| Drug | oxotremorine-M | 2.05e-04 | 81 | 151 | 5 | CID000004629 | |
| Drug | sanglifehrin A | 2.05e-04 | 44 | 151 | 4 | CID005388925 | |
| Drug | Etilefrine hydrochloride [534-87-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.11e-04 | 181 | 151 | 7 | 2930_UP | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.25e-04 | 183 | 151 | 7 | 7059_UP | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.41e-04 | 185 | 151 | 7 | 7209_DN | |
| Drug | Akti-1/2 | 2.56e-04 | 19 | 151 | 3 | CID010196499 | |
| Drug | GI-1 | 2.64e-04 | 133 | 151 | 6 | CID011957431 | |
| Drug | AC 695 | 2.66e-04 | 47 | 151 | 4 | CID000004885 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | TDRD15 ABCA1 PELI3 DHX38 LEPR TRIM5 ZNF106 CELSR2 AFF1 PLCB3 | 2.29e-06 | 291 | 148 | 10 | EFO_0008317, EFO_0020946 |
| Disease | myeloid white cell count | LIMA1 HSP90B2P TTC28 VPS8 ABCC5 LEPR ADK MET OLFM3 DPEP2 PLCB1 HFM1 RAI14 PLCB2 KIT VAV2 PLCE1 | 5.07e-06 | 937 | 148 | 17 | EFO_0007988 |
| Disease | alkaline phosphatase measurement | RALGAPA1 TDRD15 DHX38 NPEPL1 LEPR TRIM5 PHKB FRK NWD2 DPEP2 HFM1 RAI14 PRR14L CDC5L ARHGAP21 ADAMTSL2 PLCE1 | 1.43e-05 | 1015 | 148 | 17 | EFO_0004533 |
| Disease | Beta blocking agent use measurement | 2.46e-05 | 114 | 148 | 6 | EFO_0009929 | |
| Disease | very low density lipoprotein cholesterol measurement | 5.31e-05 | 260 | 148 | 8 | EFO_0008317 | |
| Disease | triglycerides in large LDL measurement | 6.44e-05 | 43 | 148 | 4 | EFO_0022319 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.08e-05 | 144 | 148 | 6 | EFO_0004611, EFO_0020943 | |
| Disease | free cholesterol in very small VLDL measurement | 9.17e-05 | 47 | 148 | 4 | EFO_0022275 | |
| Disease | total lipids in lipoprotein particles measurement | 9.96e-05 | 48 | 148 | 4 | EFO_0022309 | |
| Disease | cardiovascular disease | ARHGAP42 TDRD15 LIMA1 ADCY9 ADK PLEKHG1 CELSR2 PLCB1 PCDH18 PLCE1 | 1.10e-04 | 457 | 148 | 10 | EFO_0000319 |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.26e-04 | 51 | 148 | 4 | EFO_0022285 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.43e-04 | 224 | 148 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.47e-04 | 225 | 148 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 1.55e-04 | 227 | 148 | 7 | EFO_0020946 | |
| Disease | triglycerides in LDL measurement | 1.82e-04 | 56 | 148 | 4 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 1.82e-04 | 56 | 148 | 4 | EFO_0022235 | |
| Disease | preeclampsia, fetal genotype effect measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | dodecadienoate (12:2) measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0800572 | |
| Disease | pneumonia, COVID-19 | 2.69e-04 | 113 | 148 | 5 | EFO_0003106, MONDO_0100096 | |
| Disease | triglycerides in medium LDL measurement | 2.70e-04 | 62 | 148 | 4 | EFO_0022322 | |
| Disease | triglycerides in small LDL measurement | 3.24e-04 | 65 | 148 | 4 | EFO_0022323 | |
| Disease | coronary artery disease | ARHGAP42 TDRD15 ABCA1 PPP1R12B DHX38 CENPO TRIM5 PLEKHG1 MALRD1 CELSR2 PLCB2 PBX2 PCDH18 ARHGAP21 PLCE1 CHST3 | 3.41e-04 | 1194 | 148 | 16 | EFO_0001645 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 3.70e-04 | 121 | 148 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | C-reactive protein measurement | TDRD15 ABCA1 CFAP251 MTF2 NPEPL1 LEPR ADCY9 FRK ZNF106 FBP1 CELSR2 KCND3 KCNIP4 HFM1 KIT ARHGAP21 | 3.80e-04 | 1206 | 148 | 16 | EFO_0004458 |
| Disease | mean corpuscular hemoglobin concentration | TTC28 SLC35D2 POLR2A ABCC5 RFC1 LEPR ADCY9 ITPR2 DPEP2 PLCB1 AFF1 HFM1 PLCB3 ARHGAP21 VPS13B | 4.59e-04 | 1105 | 148 | 15 | EFO_0004528 |
| Disease | esterified cholesterol measurement | 4.78e-04 | 128 | 148 | 5 | EFO_0008589 | |
| Disease | DNA methylation | ARHGAP42 DNHD1 ABCA1 GRIN2B SUCLG1 TRIM5 KCND3 PLCB1 KCNIP4 CDH10 PLCE1 | 4.94e-04 | 656 | 148 | 11 | GO_0006306 |
| Disease | total cholesterol measurement, C-reactive protein measurement | 5.01e-04 | 31 | 148 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 5.16e-04 | 7 | 148 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | X-16935 measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0800763 | |
| Disease | muscular atrophy (implicated_via_orthology) | 5.16e-04 | 7 | 148 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | hematocrit | RALGAPA1 TDRD15 PELI3 DHX38 ITPR2 PLEKHG1 MET PLCB1 AFF1 RAI14 PLCB3 CDC5L ARHGAP21 VAV2 | 5.88e-04 | 1011 | 148 | 14 | EFO_0004348 |
| Disease | X-24747 measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0022135 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 6.86e-04 | 8 | 148 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | Hereditary Diffuse Gastric Cancer | 7.19e-04 | 293 | 148 | 7 | C1708349 | |
| Disease | Myopia | 7.54e-04 | 385 | 148 | 8 | HP_0000545 | |
| Disease | Stomach Neoplasms | 7.79e-04 | 297 | 148 | 7 | C0038356 | |
| Disease | obesity (implicated_via_orthology) | 7.79e-04 | 215 | 148 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 7.79e-04 | 215 | 148 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | Malignant neoplasm of stomach | 8.26e-04 | 300 | 148 | 7 | C0024623 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 8.78e-04 | 220 | 148 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | 2-hydroxyglutaric acid measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0010446 | |
| Disease | triglyceride change measurement, response to exercise | 8.79e-04 | 9 | 148 | 2 | EFO_0007681, EFO_0007768 | |
| Disease | X-17653 measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0800783 | |
| Disease | lipoprotein measurement, phospholipid measurement | 8.98e-04 | 85 | 148 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | Autism Spectrum Disorders | 8.98e-04 | 85 | 148 | 4 | C1510586 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 9.44e-04 | 307 | 148 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.80e-04 | 150 | 148 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.86e-04 | 225 | 148 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.04e-03 | 152 | 148 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | platelet crit | TTC28 DOCK10 ABCC5 LEPR ITPR2 ADK PHKB PLCB1 AFF1 HFM1 KIT PLCE1 RAVER1 | 1.05e-03 | 952 | 148 | 13 | EFO_0007985 |
| Disease | cholesterol in very small VLDL measurement | 1.07e-03 | 40 | 148 | 3 | EFO_0022231 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.07e-03 | 153 | 148 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.08e-03 | 229 | 148 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | lipid measurement, lipoprotein measurement | 1.11e-03 | 90 | 148 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | apolipoprotein A 1 measurement | COL7A1 ABCA1 DHX38 LEPR TRIM5 FRK CELSR2 DPEP2 AFF1 PLCB3 HERC1 KIT | 1.21e-03 | 848 | 148 | 12 | EFO_0004614 |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 1.22e-03 | 321 | 148 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | colorectal cancer, endometrial neoplasm | 1.23e-03 | 42 | 148 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.34e-03 | 239 | 148 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.46e-03 | 243 | 148 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.54e-03 | 166 | 148 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.56e-03 | 335 | 148 | 7 | EFO_0009931 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.58e-03 | 99 | 148 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.58e-03 | 99 | 148 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0008141 | |
| Disease | Myeloproliferative disease | 1.60e-03 | 12 | 148 | 2 | C0027022 | |
| Disease | neutrophil count | LIMA1 HSP90B2P TTC28 ABCC5 LEPR ITPR2 MET CD1A OLFM3 KCND3 DPEP2 PLCB1 AFF1 PLCB2 PLCB4 KIT | 1.60e-03 | 1382 | 148 | 16 | EFO_0004833 |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.60e-03 | 46 | 148 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Schizophrenia | ARHGAP32 ABCA1 GRIN2B GFRA1 ADAMTS12 ADK MET FBP1 MTOR CSNK1E PLCB1 EN2 | 1.70e-03 | 883 | 148 | 12 | C0036341 |
| Disease | major depressive episode | 1.71e-03 | 47 | 148 | 3 | EFO_0007634 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.76e-03 | 102 | 148 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 1.88e-03 | 13 | 148 | 2 | EFO_0800588 | |
| Disease | familial hyperlipidemia | 2.03e-03 | 106 | 148 | 4 | MONDO_0001336 | |
| Disease | free cholesterol in large LDL measurement | 2.16e-03 | 51 | 148 | 3 | EFO_0022176 | |
| Disease | phospholipids in very small VLDL measurement | 2.16e-03 | 51 | 148 | 3 | EFO_0022300 | |
| Disease | CD209 antigen measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0008077 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.22e-03 | 264 | 148 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | migraine disorder | 2.23e-03 | 357 | 148 | 7 | MONDO_0005277 | |
| Disease | total lipids in LDL measurement | 2.28e-03 | 52 | 148 | 3 | EFO_0022308 | |
| Disease | total phospholipids in lipoprotein particles measurement | 2.41e-03 | 53 | 148 | 3 | EFO_0022315 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.41e-03 | 53 | 148 | 3 | EFO_0022286 | |
| Disease | lipoprotein A measurement | 2.48e-03 | 112 | 148 | 4 | EFO_0006925 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.51e-03 | 15 | 148 | 2 | EFO_0007804, GO_0036273 | |
| Disease | total lipids in medium VLDL | 2.54e-03 | 54 | 148 | 3 | EFO_0022153 | |
| Disease | free cholesterol measurement | 2.56e-03 | 113 | 148 | 4 | EFO_0008591 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 2.65e-03 | 114 | 148 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 2.65e-03 | 114 | 148 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.67e-03 | 274 | 148 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | triglycerides in medium VLDL measurement | 2.68e-03 | 55 | 148 | 3 | EFO_0022155 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.76e-03 | 276 | 148 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | Carcinoma, Granular Cell | 2.82e-03 | 116 | 148 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.82e-03 | 116 | 148 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.82e-03 | 116 | 148 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.82e-03 | 116 | 148 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.82e-03 | 116 | 148 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.82e-03 | 116 | 148 | 4 | C0001418 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.82e-03 | 56 | 148 | 3 | EFO_0022279 | |
| Disease | Spondyloepiphyseal Dysplasia | 2.86e-03 | 16 | 148 | 2 | C0038015 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTVGFGTNNSEHITY | 601 | Q99459 | |
| EYHAGGSTQNSIKVA | 76 | P55263 | |
| AGGYHSLALTAKSQV | 566 | Q96Q42 | |
| IVHSATGFKQSSNLY | 916 | P11274 | |
| CTLSYQNSGKHSLGS | 1496 | Q9UIF8 | |
| ASGGLALQGIYKASH | 181 | Q7Z2Y8 | |
| GYQLHLTSLCNGSKS | 186 | O95477 | |
| AKQHNAYGGFSSTQD | 1226 | A8K2U0 | |
| SSSAYKLEAAAQAHG | 686 | A8MVX0 | |
| DGSHLTGQTLKQTYS | 161 | Q14406 | |
| NGEKSTKTIAHYSGQ | 71 | Q96IX9 | |
| INGSVANVGGTLHYK | 316 | P49753 | |
| NATQHTAGYFGSDVK | 2061 | Q9HCU4 | |
| TGQYLSSHIKGTLGT | 2346 | Q96M86 | |
| YDTLGHSAFTSGKGQ | 86 | Q9UBS3 | |
| HSSSFSLYHKGIVNG | 1111 | Q96BY7 | |
| NASNYKQLTNGHGSA | 1301 | P58397 | |
| SQGKYLLNGHFVVSA | 731 | Q8TE58 | |
| SGIHKSFEVLGYTNS | 1046 | Q8TBY9 | |
| GTKHGSSATYINGFT | 1051 | Q9ULI1 | |
| NHLKNSITSYFGAAG | 546 | Q9Y483 | |
| SASSKDTGQLYAALH | 491 | Q9H6Z4 | |
| DSSGKTALHYAAAQG | 116 | Q9P0K7 | |
| ALHYSKLSENAGIQS | 221 | Q9P0K7 | |
| YFTSGLQAGLKQSHL | 491 | Q8IY67 | |
| LNAAHYSTGKVSASF | 236 | Q13356 | |
| GVNGHLSGAYSKTAQ | 1711 | Q14571 | |
| GANGKIVYSFSSHVS | 276 | Q9HCL0 | |
| YQLALQARKGGHSST | 1186 | Q7Z6G8 | |
| AYALAVSSTKGATGH | 371 | Q9NWU1 | |
| ATGKTVISYGHCAAQ | 86 | Q8NGQ6 | |
| SQSLGYDQHGSSSGK | 461 | Q5D862 | |
| YQTGKGISTNYHASR | 306 | Q58FF3 | |
| YAVKTAVSVTQGGHS | 316 | P40425 | |
| GSSNAYLHSKRNGLL | 436 | Q9UK17 | |
| KTNGSHYFLNTGSLS | 336 | Q17RR3 | |
| SVKQGHGNLSGTSFQ | 3531 | Q8NEZ4 | |
| NYRSAISNHGSKIEG | 1876 | Q16787 | |
| NNKLSLGTYASLHGR | 421 | Q9UHB6 | |
| NTGKYTCTNKHGLSN | 91 | P10721 | |
| NLSTSHSEQEYGKAG | 176 | O95208 | |
| NGATYFGKHSGIVTS | 351 | Q8NCI6 | |
| NVSLSLLYKSSVHGG | 21 | Q53G44 | |
| GYQAHADTATKSNSL | 221 | A6NMX2 | |
| GNLYHNGEQTLTLSS | 2116 | Q15751 | |
| LHSGKVSGSFLQLAY | 121 | P06126 | |
| NSSPDSGKQLVHYTA | 456 | Q00613 | |
| GSGKTTSCQHLVQYL | 501 | Q92614 | |
| LTGAQGIATGKYHAA | 371 | Q8NDH3 | |
| GIATGKYHAAVLTNS | 376 | Q8NDH3 | |
| QAKSGSALAQLYGTS | 716 | Q9HCR9 | |
| GHNTKKASYSGVSLF | 316 | P07585 | |
| KNLTGTARYASINTH | 171 | P48730 | |
| TNGHKLLSLSSNYDA | 301 | Q8IYU2 | |
| ASSTGGFLYAQNSTK | 16 | Q6PIL6 | |
| YGGKNISSHTNIVFS | 411 | P42785 | |
| QYHTKTGILNATAGD | 146 | Q5T7B8 | |
| ARSAGHGFNATYQVK | 351 | O75074 | |
| SSCTHVTGNYRKGNA | 211 | Q86TH1 | |
| AGLSKNTSNSNGHYE | 51 | P48357 | |
| SLSVNGGASYGNHLS | 381 | P48742 | |
| AGAAEHKSQTYTNGF | 841 | Q8TE49 | |
| HKSQTYTNGFGALRD | 846 | Q8TE49 | |
| SAYSQLAGLRAHQKS | 306 | Q9H4Q4 | |
| ANKGRHSNGSQFYIT | 246 | Q8IXY8 | |
| HNSGVKYAASGQESL | 1921 | A7KAX9 | |
| ISNGGAQTYHLKASS | 151 | P22059 | |
| NNDLSHIAGKLTYAS | 111 | A2PYH4 | |
| SHNTYLTAGQLAGTS | 331 | Q01970 | |
| KAGIAHLYGIAGSTN | 51 | P09467 | |
| GQHFLYVNSSGSKEG | 1776 | Q5VYJ5 | |
| SSIQGLATIHAYNKG | 1056 | O15440 | |
| LSANGSIYNEKGTGH | 116 | O43825 | |
| HGSLQEYLQNDTGSK | 311 | P42685 | |
| YTANSKGGVTTQALA | 261 | P07199 | |
| VGGHSGSSYLNTVQK | 531 | Q9NXS3 | |
| DFTGINTKLSGNTHY | 706 | Q4AC94 | |
| NYLSFQDSASGKHGG | 816 | Q96BY6 | |
| ATGSGIKSHNSALYS | 436 | Q99704 | |
| SALYSQVQKSGASGS | 446 | Q99704 | |
| SNGNYEKEGLGASSH | 416 | P56159 | |
| IFNIHSGNGSLYTSK | 431 | Q9Y6N8 | |
| YKGGNTFTGLALTHV | 251 | Q9P218 | |
| SNQGDQKGSTYSRHN | 346 | Q9UKT4 | |
| LLITSAQKSHSGAYQ | 371 | Q8TD84 | |
| SQATKLTYNHGGITG | 271 | Q9Y6R7 | |
| KNSSYVHGGLDSNGK | 36 | Q13283 | |
| DTGGNTYTAKALKHA | 886 | A8TX70 | |
| VSQTYSKNHDSGGVI | 1046 | O60503 | |
| LSAQLTHASSLGYNG | 176 | Q9NX46 | |
| THASSLGYNGAILQA | 181 | Q9NX46 | |
| RNYENHSSGGKALAQ | 366 | Q9UHN6 | |
| KSSLANYLHKNGETS | 121 | O95243 | |
| HATPAGFYSSVNKNS | 131 | O43248 | |
| TSYHSQQKQSGDNGS | 56 | Q8NEP3 | |
| AKGVHSFYNNISGLT | 226 | Q9H4A9 | |
| NSLYAKAVKNHSSGT | 411 | O60381 | |
| QAYHFTGLSGKLTSR | 106 | Q9BU64 | |
| SYKGGNTRTGAAILH | 111 | Q02388 | |
| HQFVSLSTSGGKYQF | 461 | Q9H583 | |
| QGLYNHSTTAKEGKS | 316 | P19622 | |
| CGTLYVTNSHLTGAK | 401 | Q96PB7 | |
| KYNNGSTELHSSSVG | 226 | Q93100 | |
| LNDSHYGQQDKGTSL | 1176 | Q5THK1 | |
| QSNALVGLLGYSSHQ | 326 | P42345 | |
| TLTGNYLNSGNSRHI | 676 | P08581 | |
| YLNSGNSRHISIGGK | 681 | P08581 | |
| YVGNHISGLSSTSKL | 101 | Q76EJ3 | |
| SSHNTYLTGRQFGGK | 326 | Q15147 | |
| SSALYSNLSGHRGSQ | 371 | O15061 | |
| TTSLKGKTGNNYRHN | 1166 | B5MCY1 | |
| SHNTYLTGHQLKGES | 1406 | Q9P212 | |
| LIKYTDGDQNHQSGS | 91 | Q9H0K6 | |
| GFYSNGAASSVSTKH | 701 | P35251 | |
| ISAAEGNKSYSGSIQ | 741 | A6NI28 | |
| VSKALSNRGQHSISY | 116 | Q8N2H9 | |
| YSHSSAAQAQGIIKL | 106 | Q9UPW6 | |
| GASLFASNIGSNHYV | 71 | Q9NY91 | |
| VYNSSHFKSLATGGN | 446 | Q8N3P4 | |
| YLSTHGFLSNLKDTG | 631 | Q8NEZ3 | |
| SRLSGGGHYNSQKTL | 161 | Q8TAV0 | |
| GGHYNSQKTLSTSSI | 166 | Q8TAV0 | |
| GQSIQLASQKHYGLS | 466 | Q5T5J6 | |
| NTEGKGTAYSSAASH | 431 | Q13546 | |
| LSLGYSHSSAAQAKG | 116 | Q01826 | |
| KQGTFHSQQALEYGT | 66 | P53597 | |
| GSGISGNTAINYKHS | 256 | Q8N9L9 | |
| NHGYTSGSGQKLFTF | 46 | Q9BY15 | |
| GSSKVHGSSNNSKGY | 226 | P51825 | |
| HGSSNNSKGYCPAKS | 231 | P51825 | |
| QAAHDGSGIYSTQKN | 406 | Q7LGC8 | |
| ASKSYNQSGLVAGAI | 131 | Q96FZ5 | |
| TGILGSQSITSGKHY | 346 | Q9C035 | |
| GKAFSTGSYLVQHQR | 406 | P17039 | |
| AQLNHSSYGNGISSA | 861 | Q5W0Q7 | |
| KEAVHSGSAYQGKTS | 2906 | Q8N2C7 | |
| DKHSILTNTGGSQAY | 1821 | Q6GYQ0 | |
| SGSGLYAQKFLHSSF | 321 | Q9UIV8 | |
| TFHYAGVSAKNVTLG | 1106 | P24928 | |
| KANGSHYALTAIGLG | 6 | Q9NW97 | |
| KLLHVNTASGYGNSS | 56 | O75635 | |
| ETGSGKTTQLTQYLH | 556 | Q92620 | |
| HNTYLTAGQLAGNSS | 331 | Q9NQ66 | |
| SHNTYLTAGQFSGLS | 326 | Q00722 | |
| GKGYSQSSHLQGHQR | 746 | Q9UJW7 | |
| YHSAFAQQSKIHSGG | 256 | P51504 | |
| KAQAYGELGSLHSQL | 956 | Q96AY4 | |
| KGQTAYHKTGSTQLF | 101 | O95789 | |
| GTHQQHGFLSLTYTK | 1441 | Q7Z7G8 | |
| GKGFYTNSQLSSHQR | 406 | Q12901 | |
| GSLSTKLHSRAYQQA | 221 | Q99541 | |
| AGHSKGSLYAQTDGT | 706 | Q9ULL1 | |
| QQTDNLLKSHASGTY | 681 | P52735 | |
| GHYTIKNGDSLQLSN | 811 | P48553 | |
| LKSGNYSGHSDGISS | 346 | Q5T5U3 | |
| QTSGKNAALYTGSSD | 1581 | Q9H2Y7 | |
| KNLTGTARYASINTH | 171 | P49674 | |
| SGATALHVAAAKGYS | 216 | O60237 | |
| KLHNYSTTVTGQNSG | 1221 | Q13224 | |
| NGSSNGHVYEKLSSI | 1466 | Q13224 |